Filing Details

Accession Number:
0001640334-22-000918
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-06 06:00:47
Reporting Period:
2022-05-02
Accepted Time:
2022-05-06 06:00:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1018735 Nymox Pharmaceutical Corp NYMX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651844 George James Robinson 10 East Lee Street
Suite 2705
Baltimore MD 21202
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-02 1,151,515 $1.65 4,702,065 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2022-05-02 1,151,515 $0.00 1,151,515 $2.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,151,515 2022-03-17 2027-04-12 No 4 P Direct